The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InBlackstone and TPG have officially completed the $17.2 billion acquisition of medical technology leader Hologic, Inc., priced at $79 per share. Following the closure, Hologic (HOLX) common stock has ceased trading and was delisted from the Nasdaq as the company transitions to private ownership. The transaction featured significant minority investments from global sovereign wealth funds, including the Abu Dhabi Investment Authority (ADIA) and Singapore’s GIC. To lead the next phase of growth, José E. Almeida, former CEO of Baxter International, has been appointed as the new Chief Executive Officer. The acquisition is designed to accelerate Hologic's innovation in medical diagnostics and women's health products. This massive leveraged buyout signals robust private equity appetite and sustained confidence in the global MedTech sector.